Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huopio, H.
Right arrow Articles by Laakso, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huopio, H.
Right arrow Articles by Laakso, M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 25:101-106, 2002
© 2002 by the American Diabetes Association, Inc.


Pathophysiology/Complications
Original Article

Carriers of an Inactivating ß-Cell ATP-Sensitive K+ Channel Mutation Have Normal Glucose Tolerance and Insulin Sensitivity and Appropriate Insulin Secretion

Hanna Huopio, MD1, Ilkka Vauhkonen, MD2, Jorma Komulainen, MD1, Leo Niskanen, MD2, Timo Otonkoski, MD3 and Markku Laakso, MD2

1 Department of Pediatrics, University of Kuopio, Kuopio, Finland
2 Department of Medicine, University of Kuopio, Kuopio, Finland
3 Transplantation Laboratory, Haartman Institute, University of Helsinki, and the Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland

OBJECTIVE—Insulin release from the pancreatic ß-cells is controlled by ATP-sensitive K+ (KATP) channels, which consist of a hetero-octameric complex of four sulfonylurea receptor 1 (SUR1) and four Kir6.2 proteins. Mutations in the SUR1 gene are the major cause of congenital hyperinsulinemia (CHI). Despite the hereditary nature of CHI, studies of glucose homeostasis in heterozygous relatives of CHI patients are lacking. Theoretically, in the heterozygous state of the SUR1 gene mutation, only 1 of 16 KATP channels consists of entirely normal subunits. The aim of our study was to investigate in vivo the glucose homeostasis of heterozygous SUR1 mutation carriers.

RESEARCH DESIGN AND METHODS—We studied 8 parents of CHI patients, all 8 of whom were heterozygous for the inactivating SUR1 mutation V187D, and 10 matched control subjects. We evaluated glucose tolerance and insulin secretory capacity with oral and intravenous glucose tests, rates of whole-body glucose uptake with hyperinsulinemic-euglycemic clamps, C-peptide response to hypoglycemia during hyperinsulinemic-hypoglycemic clamp, and function of the KATP channels with intravenous tolbutamide test.

RESULTS—Carriers of the V187D substitution had normal glucose tolerance, normal tissue sensitivity to insulin, and no signs of inappropriate insulin secretion. The normal insulin response to tolbutamide indicated that heterozygosity for the V187D mutation did not impair KATP channel function.

CONCLUSIONS—We conclude that the heterozygous carriers of the SUR1 mutation had normal glucose metabolism and insulin secretion, indicating that carriers of recessive KATP channel mutations are unlikely to be at an increased risk of hypoglycemia or other disturbances in glucose metabolism.

Abbreviations: CHI, congenital hyperinsulinemia • KATP, ATP-sensitive K+ channel • IVGTT, intravenous glucose tolerance test • OGTT, oral glucose tolerance test • RIA, radioimmunoassay • SUR1, sulfonylurea receptor 1


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
M. S. Remedi, Joseph. C. Koster, K. Markova, S. Seino, T. Miki, B. L. Patton, M. L. McDaniel, and C. G. Nichols
Diet-Induced Glucose Intolerance in Mice With Decreased {beta}-Cell ATP-Sensitive K+ Channels
Diabetes, December 1, 2004; 53(12): 3159 - 3167.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. J. DUNNE, K. E. COSGROVE, R. M. SHEPHERD, A. AYNSLEY-GREEN, and K. J. LINDLEY
Hyperinsulinism in Infancy: From Basic Science to Clinical Disease
Physiol Rev, January 1, 2004; 84(1): 239 - 275.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Huopio, J. Jaaskelainen, J. Komulainen, R. Miettinen, P. Karkkainen, M. Laakso, P. Tapanainen, R. Voutilainen, and T. Otonkoski
Acute Insulin Response Tests for the Differential Diagnosis of Congenital Hyperinsulinism
J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4502 - 4507.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L. M. 't Hart, T. W. van Haeften, J. M. Dekker, M. Bot, R. J. Heine, and J. A. Maassen
Variations in Insulin Secretion in Carriers of the E23K Variant in the KIR6.2 Subunit of the ATP-Sensitive K+ Channel in the {beta}-Cell
Diabetes, October 1, 2002; 51(10): 3135 - 3138.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Huopio, S.-L. Shyng, T. Otonkoski, and C. G. Nichols
KATP channels and insulin secretion disorders
Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E207 - E216.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.